Mel Schatz
Directeur/Membre du Conseil chez Sword Bio, Inc.
Profil
Mel Schatz is currently a Director at Sword Bio, Inc. and Brightwater Medical, Inc. He previously served as President & Chief Executive Officer at Crux Biomedical, Inc. and Bacchus Vascular, Inc. He also held positions as a Director at MicroPhage, Inc. and InterVene, Inc. and as Vice President at Abbott Laboratories.
Mr. Schatz earned an MBA from Rockhurst University and an undergraduate degree from the University of Maryland.
Postes actifs de Mel Schatz
| Sociétés | Poste | Début |
|---|---|---|
Sword Bio, Inc.
 Sword Bio, Inc. Medical/Nursing ServicesHealth Services Sword Diagnostics, Inc. provides next generation detection technology to life scientists. It offers IL-22, IL-1Beta, IL-33, IL-23 and ELISA boosters. The company was founded by David Dingott in 2004 and is headquartered in Summit Argo, IL. | Directeur/Membre du Conseil | - |
Brightwater Medical, Inc.
 Brightwater Medical, Inc. Medical SpecialtiesHealth Technology Brightwater Medical, Inc. develops medical devices. It offers ConvertX Stent, a device that can be converted from a catheter to a nephroureteral stent without a second interventional procedure. The company was founded by Bob Smouse in January 2014 and is headquartered in Temecula, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Mel Schatz
| Sociétés | Poste | Fin |
|---|---|---|
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | 01/01/2001 |
InterVene, Inc.
 InterVene, Inc. Electronic Equipment/InstrumentsElectronic Technology InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | - |
MicroPhage, Inc.
 MicroPhage, Inc. Medical/Nursing ServicesHealth Services MicroPhage, Inc. provides clinical product development services. The firm develops and markets bacterial identification and antibiotic susceptibility through its bacteriophage-based amplification platform for immunoassay diagnostics. The company was founded by Jack Wheeler and Kent Voorhees in June 2002 and is headquartered in Longmont, CO. | Directeur/Membre du Conseil | - |
Bacchus Vascular, Inc.
 Bacchus Vascular, Inc. Medical SpecialtiesHealth Technology Bacchus Vascular, Inc. manufactures and sells medical devices. It provides treatments for peripheral vascular diseases. The company was founded by Nellix Michael and Thomas J. Fogarthy in 1999 and is headquartered in Santa Clara, CA. | President | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Formation de Mel Schatz
| Rockhurst University | Masters Business Admin |
| University of Maryland | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 8 |
|---|---|
Crux Biomedical, Inc.
 Crux Biomedical, Inc. Medical SpecialtiesHealth Technology Crux Biomedical, Inc. develops and manufactures medical devices. The company was founded by Thomas Fogarty and Frank Arko in August 2004 and is headquartered in San Diego, CA. | Health Technology |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
| Marion Laboratories | Distribution Services |
Bacchus Vascular, Inc.
Bacchus Vascular, Inc. Medical SpecialtiesHealth Technology Bacchus Vascular, Inc. manufactures and sells medical devices. It provides treatments for peripheral vascular diseases. The company was founded by Nellix Michael and Thomas J. Fogarthy in 1999 and is headquartered in Santa Clara, CA. | Health Technology |
MicroPhage, Inc.
MicroPhage, Inc. Medical/Nursing ServicesHealth Services MicroPhage, Inc. provides clinical product development services. The firm develops and markets bacterial identification and antibiotic susceptibility through its bacteriophage-based amplification platform for immunoassay diagnostics. The company was founded by Jack Wheeler and Kent Voorhees in June 2002 and is headquartered in Longmont, CO. | Health Services |
InterVene, Inc.
InterVene, Inc. Electronic Equipment/InstrumentsElectronic Technology InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA. | Electronic Technology |
Sword Bio, Inc.
Sword Bio, Inc. Medical/Nursing ServicesHealth Services Sword Diagnostics, Inc. provides next generation detection technology to life scientists. It offers IL-22, IL-1Beta, IL-33, IL-23 and ELISA boosters. The company was founded by David Dingott in 2004 and is headquartered in Summit Argo, IL. | Health Services |
Brightwater Medical, Inc.
Brightwater Medical, Inc. Medical SpecialtiesHealth Technology Brightwater Medical, Inc. develops medical devices. It offers ConvertX Stent, a device that can be converted from a catheter to a nephroureteral stent without a second interventional procedure. The company was founded by Bob Smouse in January 2014 and is headquartered in Temecula, CA. | Health Technology |
